Viemed Healthcare to acquire Home Medical Products for $31.75M in cash

VIEMED HEALTHCARE, INC.

Purchase price of $31.75M cash for 100% equity; expected closing in June 2023.
HMP generated $28M net revenue and $6.8M Adjusted EBITDA in 2022.
Acquisition adds 181 employees and ~44,340 patients across TN, AL, MS.
HMP CEO Jason Shiflet and founder David Steele expected to join Viemed post-close.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

VIEMED HEALTHCARE, INC. entered into Purchase Agreement with Home Medical Products, Inc., Kevin Atkins and David Steele valued at approximately $31.75 million in cash (effective 2023-04-18).

Action: entry
Agreement: asset purchase
Counterparty: Home Medical Products, Inc., Kevin Atkins and David Steele
Value: approximately $31.75 million in cash
Effective: 2023-04-18

Exact text from the filing

On April 18, 2023, Viemed, Inc. ("Viemed"), a wholly-owned subsidiary of Viemed Healthcare, Inc. (the "Company"), entered into a definitive stock purchase agreement (the “Purchase Agreement”) with Home Medical Products, Inc., (“HMP”), Kevin Atkins and David Steele (collectively, the “Stockholders”), and David Steele, as the representative of the Stockholders, to acquire HMP for approximately $31.75 million in cash, subject to net working capital and other adjustments.

View on SEC.gov

Browse all material agreements →

VIEMED HEALTHCARE, INC. filing history →

Source: SEC EDGAR

accession 0001729149-23-000050

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.